IPOX

The IPOX® Week, March 30, 2020

IPOX® Indexes rise sharply after U.S. Futures and Option expiration as massive global stimulus outweigh COVID-19. IPOX® Global Alternative Strategy on course for best quarterly performance on record. IPO Deal-flow Review & Outlook: Much anticipated cancer drugs developer InnoCare Pharma (9969 HK) surges in H.K. trading debut. Quiet April ahead from global New Listings. IPOX®.. Read more

The IPOX® Week, March 23, 2020

IPOX® International (ETF: FPX) outperforms as IPOX Europe (IXTE) gains. Another rough week for U.S. equities. Amid huge moves in global equity indexes spreads, IPOX Global Alternative Strategy soars +4.47% +25.39% YTD. IPO Deal-flow Review & Outlook: Asset Manager Ninety One (N91 LN) completes London Spin-off. Hong Kong awaits hot InnoCare Pharma (9969 HK) IPO... Read more

The IPOX® Week, March 16, 2020

IPOX Indexes fall with markets. IPOX 100 U.S. (ETF: FPX) suffers 3rd largest weekly decline since 1990; closes well above December 2018 lows. Amid turmoil, IPOX Global Alternative strategy shines. IPO Deal-flow Review & Outlook: New IPOs tumble over COVID-19 market turmoil. Investec’s asset management unit Ninety One proceeds with London offer. IPOX Indexes fall.. Read more

The IPOX® Week, March 9, 2020

After week of steep drop, IPOX Indexes trade mixed. IPOX 100 U.S. (ETF: FPX) sheds -0.94% as sell-off extends to high-growth stocks. Gains in IPOX China Core (CNI) drives IPOX International (ETF: FPXI) to strong week. IPO Deal-flow Review & Outlook: Canadian waste management firm GFL Environmental (GFL US) debuted. 3 deals expected this week.. Read more

The IPOX® Week, March 2, 2020

IPOX Indexes turn mixed during February, but outperform YTD as COVID-19 fears drive big selling wave in global equities. IPOX China (CNI) adds +5.63% during last month. IPO Deal-flow Review & Outlook: February concludes with solid deal flow and robust initial showing. GFL Environmental on track for its $1.5 billion IPO relaunch. IPOX Indexes turn.. Read more

Try the demo

Compare Platforms
Check the background of this firm on FINRA's BrokerCheck

Our website uses cookies to improve the performance of our site, to analyze the traffic to our site, and to personalize your experience of the site. You can control cookies through your browser settings. Please find more information on the cookies used on our site in our Privacy Policy. By clicking OK, you agree to allow us to collect information through cookies.

OK